[S-8] GRI Bio, Inc. Employee Benefit Plan Registration
GRI Bio, Inc. filed a Form S-8 to register an additional 400,000 shares of common stock reserved for issuance under its Amended and Restated 2018 Equity Incentive Plan. The filing incorporates prior Form S-8 registrations by reference and includes the amended plan and related award agreement forms as exhibits. The registration increases the pool available for employee stock awards but does not disclose total shares outstanding or quantify potential dilution.
GRI Bio, Inc. ha depositato un modulo S-8 per registrare ulteriori 400.000 azioni di azioni ordinarie destinate all'emissione ai sensi del suo Piano di Incentivi Azionari 2018 modificato e riformulato. Il deposito incorpora per riferimento le precedenti registrazioni S-8 e allega il piano modificato e i relativi moduli di attribuzione come esibizioni. La registrazione aumenta il monte disponibile per i premi azionari ai dipendenti, ma non indica il numero totale di azioni in circolazione n茅 quantifica l'eventuale diluizione.
GRI Bio, Inc. present贸 un formulario S-8 para registrar 400.000 acciones adicionales de acciones ordinarias reservadas para emisi贸n bajo su Plan de Incentivos de Capital enmendado y restablecido de 2018. La presentaci贸n incorpora por referencia registros S-8 anteriores e incluye el plan enmendado y los formularios de acuerdo de adjudicaci贸n relacionados como anexos. La inscripci贸n ampl铆a el fondo disponible para premios accionarios a empleados, pero no revela el n煤mero total de acciones en circulaci贸n ni cuantifica la posible diluci贸n.
GRI Bio, Inc.電� 靾橃爼路鞛爼牍勲悳 2018 欤检嫕 鞚胳劶韹半笇 瓿勴殟鞐� 霐半澕 氚滍枆鞚� 鞙勴暣 鞓堨暯霅� 於旉皜 400,000欤�鞚� 氤错喌欤茧ゼ 霌彪頃橁赴 鞙勴暣 Form S-8鞚� 鞝滌稖頄堨姷雼堧嫟. 鞚� 鞝滌稖靹滊姅 鞚挫爠 Form S-8 霌彪鞚� 彀胳“搿� 韽暔頃橁碃, 靾橃爼霅� 瓿勴殟靹� 氚� 甏�霠� 靾橃棳 瓿勳暯靹� 鞏戩嫕鞚� 歃濍箼靹滊搿� 觳秬頃╇媹雼�. 鞚措矆 霌彪鞙茧 歆侅洂 鞀ろ啞 氤挫儊鞐� 靷毄頃� 靾� 鞛堧姅 頀�鞚� 電橃柎雮橃毵�, 齑� 氚滍枆 欤检嫕靾橂倶 鞛犾灛鞝� 頋劃 攴滊電� 瓿店皽頃橃 鞎婌晿鞀惦媹雼�.
GRI Bio, Inc. a d茅pos茅 un formulaire S鈥�8 pour enregistrer 400鈥�000 actions ordinaires suppl茅mentaires r茅serv茅es 脿 l'茅mission dans le cadre de son Plan d'int茅ressement en actions 2018 modifi茅 et refondu. Le d茅p么t int猫gre par renvoi les enregistrements S鈥�8 ant茅rieurs et inclut le plan modifi茅 ainsi que les formulaires d'accord d'attribution correspondants en annexes. L'enregistrement augmente le vivier disponible pour les attributions d'actions aux employ茅s, mais ne communique pas le nombre total d'actions en circulation ni ne quantifie la dilution potentielle.
GRI Bio, Inc. hat ein Formular S-8 eingereicht, um zus盲tzliche 400.000 Aktien von Stammaktien zu registrieren, die f眉r die Ausgabe unter seinem ge盲nderten und neu gefassten Aktienanreizplan 2018 reserviert sind. Die Einreichung verweist auf fr眉here Form S-8-Registrierungen und enth盲lt den ge盲nderten Plan sowie die zugeh枚rigen Zuteilungsvereinbarungen als Anlagen. Die Registrierung vergr枚脽ert den verf眉gbaren Bestand f眉r Mitarbeiteraktienzuteilungen, nennt jedoch weder die insgesamt ausstehenden Aktien noch beziffert sie eine m枚gliche Verw盲sserung.
- None.
- None.
Insights
TL;DR: Registration of 400,000 shares for employee awards is routine; material impact cannot be assessed from this filing alone.
The Form S-8 registers an additional 400,000 shares for issuance under the company's amended equity incentive plan and incorporates prior S-8 filings by reference. As a securities filing, this enables the company to grant options and RSUs to employees, directors or consultants. The document contains no information on total shares outstanding or award terms, so the filing itself is procedural and its investor impact is neutral without additional capitalization data.
TL;DR: Expands the equity award pool and provides the legal framework for grants; the practical effect depends on award details not included here.
The exhibits include the Amended and Restated 2018 Equity Incentive Plan and sample award agreement forms, which establish the contractual mechanisms to issue stock options and restricted stock units. This filing is necessary to make future grants administratively compliant. Without disclosure of award pricing, vesting schedules or outstanding share count, the filing does not by itself reveal the scope or cost of forthcoming compensation expenses.
GRI Bio, Inc. ha depositato un modulo S-8 per registrare ulteriori 400.000 azioni di azioni ordinarie destinate all'emissione ai sensi del suo Piano di Incentivi Azionari 2018 modificato e riformulato. Il deposito incorpora per riferimento le precedenti registrazioni S-8 e allega il piano modificato e i relativi moduli di attribuzione come esibizioni. La registrazione aumenta il monte disponibile per i premi azionari ai dipendenti, ma non indica il numero totale di azioni in circolazione n茅 quantifica l'eventuale diluizione.
GRI Bio, Inc. present贸 un formulario S-8 para registrar 400.000 acciones adicionales de acciones ordinarias reservadas para emisi贸n bajo su Plan de Incentivos de Capital enmendado y restablecido de 2018. La presentaci贸n incorpora por referencia registros S-8 anteriores e incluye el plan enmendado y los formularios de acuerdo de adjudicaci贸n relacionados como anexos. La inscripci贸n ampl铆a el fondo disponible para premios accionarios a empleados, pero no revela el n煤mero total de acciones en circulaci贸n ni cuantifica la posible diluci贸n.
GRI Bio, Inc.電� 靾橃爼路鞛爼牍勲悳 2018 欤检嫕 鞚胳劶韹半笇 瓿勴殟鞐� 霐半澕 氚滍枆鞚� 鞙勴暣 鞓堨暯霅� 於旉皜 400,000欤�鞚� 氤错喌欤茧ゼ 霌彪頃橁赴 鞙勴暣 Form S-8鞚� 鞝滌稖頄堨姷雼堧嫟. 鞚� 鞝滌稖靹滊姅 鞚挫爠 Form S-8 霌彪鞚� 彀胳“搿� 韽暔頃橁碃, 靾橃爼霅� 瓿勴殟靹� 氚� 甏�霠� 靾橃棳 瓿勳暯靹� 鞏戩嫕鞚� 歃濍箼靹滊搿� 觳秬頃╇媹雼�. 鞚措矆 霌彪鞙茧 歆侅洂 鞀ろ啞 氤挫儊鞐� 靷毄頃� 靾� 鞛堧姅 頀�鞚� 電橃柎雮橃毵�, 齑� 氚滍枆 欤检嫕靾橂倶 鞛犾灛鞝� 頋劃 攴滊電� 瓿店皽頃橃 鞎婌晿鞀惦媹雼�.
GRI Bio, Inc. a d茅pos茅 un formulaire S鈥�8 pour enregistrer 400鈥�000 actions ordinaires suppl茅mentaires r茅serv茅es 脿 l'茅mission dans le cadre de son Plan d'int茅ressement en actions 2018 modifi茅 et refondu. Le d茅p么t int猫gre par renvoi les enregistrements S鈥�8 ant茅rieurs et inclut le plan modifi茅 ainsi que les formulaires d'accord d'attribution correspondants en annexes. L'enregistrement augmente le vivier disponible pour les attributions d'actions aux employ茅s, mais ne communique pas le nombre total d'actions en circulation ni ne quantifie la dilution potentielle.
GRI Bio, Inc. hat ein Formular S-8 eingereicht, um zus盲tzliche 400.000 Aktien von Stammaktien zu registrieren, die f眉r die Ausgabe unter seinem ge盲nderten und neu gefassten Aktienanreizplan 2018 reserviert sind. Die Einreichung verweist auf fr眉here Form S-8-Registrierungen und enth盲lt den ge盲nderten Plan sowie die zugeh枚rigen Zuteilungsvereinbarungen als Anlagen. Die Registrierung vergr枚脽ert den verf眉gbaren Bestand f眉r Mitarbeiteraktienzuteilungen, nennt jedoch weder die insgesamt ausstehenden Aktien noch beziffert sie eine m枚gliche Verw盲sserung.
| Delaware | 82-4369909 | |||||||||||||
| (State or other jurisdiction | (IRS Employer Identification No.) | |||||||||||||
| of incorporation) | ||||||||||||||
Large Accelerated Filer | ☐ | Accelerated Filer | ☐ | |||||||||||
Non-Accelerated Filer | ☒ | Smaller Reporting Company | ☒ | |||||||||||
Emerging Growth Company | ☒ | |||||||||||||
| Exhibit No. | Description | Filed Herewith | Form | Incorporated by Reference File No. | Date Filed | |||||||||||||||||||||||||||
| 4.1 | Amended and Restated Certificate of Incorporation, as amended. | 10-K | 001-40034 | 3/28/2024 | ||||||||||||||||||||||||||||
| 4.2 | Amended and Restated Bylaws. | 8-K/A | 001-40034 | 5/26/2023 | ||||||||||||||||||||||||||||
| 4.3 | Specimen Common Stock Certificate. | S-1 | 333-249636 | 10/23/2020 | ||||||||||||||||||||||||||||
| 5.1 | Opinion of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. | X | ||||||||||||||||||||||||||||||
| 23.1 | Consent of Sadler, Gibb & Associates, LLC, Independent Registered Public Accounting Firm. | X | ||||||||||||||||||||||||||||||
| 23.3 | Consent of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. (included legal opinion filed as Exhibit 5.1). | X | ||||||||||||||||||||||||||||||
| 24.1 | Power of Attorney (included on signature page). | X | ||||||||||||||||||||||||||||||
| 99.1# | Amended and Restated GRI Bio, Inc. 2018 Equity Incentive Plan. | 8-K | 001-40034 | 8/13/2025 | ||||||||||||||||||||||||||||
| 99.2# | Form of Non-Qualified Stock Option Agreement under the Registrant’s Amended and Restated 2018 Equity Incentive Plan. | S-1 | 333-249636 | 10/23/2020 | ||||||||||||||||||||||||||||
| 99.3# | Form of Incentive Stock Option Agreement under the Registrant’s Amended and Restated 2018 Equity Incentive Plan. | S-1 | 333-249636 | 10/23/2020 | ||||||||||||||||||||||||||||
| 99.4# | Form of Restricted Stock Unit Agreement under the Registrant’s Amended and Restated 2018 Equity Incentive Plan. | X | ||||||||||||||||||||||||||||||
| 107 | Filing fee table. | X | ||||||||||||||||||||||||||||||
| GRI BIO, INC. | ||||||||
| By: | /s/ W. Marc Hertz, Ph.D. | |||||||
| W. Marc Hertz, Ph.D. | ||||||||
| President and Chief Executive Officer | ||||||||
| Signature | Title | Date | ||||||||||||
| /s/ W. Marc Hertz, Ph.D. | President, Chief Executive Officer and Director | August 13, 2025 | ||||||||||||
| W. Marc Hertz, Ph.D. | (Principal Executive Officer) | |||||||||||||
| /s/ Leanne Kelly | Chief Financial Officer | August 13, 2025 | ||||||||||||
| Leanne Kelly | (Principal Financial and Accounting Officer) | |||||||||||||
| /s/ David Szekeres | Director, Chairperson of the Board | August 13, 2025 | ||||||||||||
| David Szekeres | ||||||||||||||
| /s/ David Baker | Director | August 13, 2025 | ||||||||||||
| David Baker | ||||||||||||||
| /s/ Roelof Rongen | Director | August 13, 2025 | ||||||||||||
| Roelof Rongen | ||||||||||||||
| /s/ Camilla V. Simpson, M.Sc. | Director | August 13, 2025 | ||||||||||||
| Camilla V. Simpson, M.Sc. | ||||||||||||||
Source:
FAQ
What did GRI (GRI) register on this Form S-8?
Which plan will the newly registered shares be issued under?
Does the filing include the plan documents and award forms?
Will this filing by itself tell me the dilution effect of the new shares?
Does the Form S-8 incorporate prior filings?
